Search research articles
Contact Us
Filters
Showing results (151-160 of 199) with videos related to
Page
of 20
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 29, 2021
Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy
C Braegelmann, D Niebel, S Ferring-Schmitt, et al.
Human Immunology
|
September 1, 1994
CD1 expression is not affected by human peptide transporter deficiency
D Hanau, D Fricker, T Bieber, et al.
The British Journal of Dermatology
|
June 14, 2005
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
S Reitamo, J P Ortonne, C Sand, et al.
The New England Journal of Medicine
|
September 19, 1997
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group
T Ruzicka, T Bieber, E Schöpf, et al.
International Reviews of Immunology
|
January 1, 1997
Functions of Fc receptors on human dendritic Langerhans cells
H de la Salle, H Haegel-Kronenberger, H Bausinger, et al.
Allergy
|
June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone
J I Silverberg, J P Thyssen, A S Paller, et al.
Allergy
|
November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study
R Foelster Holst, S Reitamo, R Yankova, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2007
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study
C Bussmann, L Maintz, J Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 1998
5-Lipoxygenase expression in Langerhans cells of normal human epidermis
R Spanbroek, H J Stark, U Janssen-Timmen, et al.
The Journal of Investigative Dermatology
|
November 1, 1992
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?
C de la Salle, M E Esposito-Farese, T Bieber, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 199) with videos related to
Sort By:
Page
of 20
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 29, 2021
Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy
C Braegelmann, D Niebel, S Ferring-Schmitt, et al.
Human Immunology
|
September 1, 1994
CD1 expression is not affected by human peptide transporter deficiency
D Hanau, D Fricker, T Bieber, et al.
The British Journal of Dermatology
|
June 14, 2005
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
S Reitamo, J P Ortonne, C Sand, et al.
The New England Journal of Medicine
|
September 19, 1997
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group
T Ruzicka, T Bieber, E Schöpf, et al.
International Reviews of Immunology
|
January 1, 1997
Functions of Fc receptors on human dendritic Langerhans cells
H de la Salle, H Haegel-Kronenberger, H Bausinger, et al.
Allergy
|
June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone
J I Silverberg, J P Thyssen, A S Paller, et al.
Allergy
|
November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study
R Foelster Holst, S Reitamo, R Yankova, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2007
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study
C Bussmann, L Maintz, J Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 1998
5-Lipoxygenase expression in Langerhans cells of normal human epidermis
R Spanbroek, H J Stark, U Janssen-Timmen, et al.
The Journal of Investigative Dermatology
|
November 1, 1992
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?
C de la Salle, M E Esposito-Farese, T Bieber, et al.
Page
of 20